Disclaimer

Our systems have detected that you are using a computer with an IP address located in the USA.
If you are currently not located in the USA, please click “Continue” in order to access our Website.

Local restrictions - provision of cross-border services

Swissquote Bank Ltd (“Swissquote”) is a bank licensed in Switzerland under the supervision of the Swiss Financial Market Supervisory Authority (FINMA). Swissquote is not authorized as a bank or broker by any US authority (such as the CFTC or SEC) neither is it authorized to disseminate offering and solicitation materials for offshore sales of securities and investment services, to make financial promotion or conduct investment or banking activity in the USA whatsoever.

This website may however contain information about services and products that may be considered by US authorities as an invitation or inducement to engage in investment activity having an effect in the USA.

By clicking “Continue”, you confirm that you have read and understood this legal information and that you access the website on your own initiative and without any solicitation from Swissquote.

Research Market strategy
by Swissquote Analysts
The near terms verdict is that OPEC+ reduction in crude oil output will keep the price supported (wti around $59 handle), considering worldwide glut and general habit of members to cheat. The price action of black gold has disappointe...
11.12.2019
A New York state judge found Exxon Mobil Corp. not guilty of fraud, saying that the New York state attorney general had failed to establish the oil giant had deceived its investors about how it accounted for the cost of future climate-change regulations. The verdict, which capped a nearly three...
11.12.2019
Global equities fell lower on Tuesday morning ahead of tomorrow FOMC meeting, with front month futures on the S&P 500 erasing Friday’s gains. The effect of the better than expected NFP figures didn’t last long. S&P futures are...
10.12.2019
Merck & Co. said it is buying ArQule Inc. for about $2.7 billion, adding to its portfolio of cancer treatments beyond the company's top-selling immunotherapy drug Keytruda. The purchase price, at $20 a share in cash, is more than double Friday's closing price of $9.66 for ArQule, a...
10.12.2019
Asian markets has opened on a positive note following Friday's US equity markets strong upside reversal. Supporting renewed risk appetite is news that China had allowed exclusion of key US agricultural good from tariffs, lowering worr...
09.12.2019
OPEC and its allies completed a new production pact to deepen their oil-output cuts, delegates said Friday. The 24-nation consensus coincides with the initial public offering of Saudi Arabia's state-controlled national oil company, Aramco, and illustrates a renewed assertiveness from the...
09.12.2019
 
Live chat